US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 2.4700
  • -0.1300-5.00%
Close Nov 7 16:00 ET
  • 2.6000
  • +0.1300+5.26%
Post 16:57 ET
6.69MMarket Cap1.53P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
-91.05%297K
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
-91.05%297K
--0
--0
Cost of revenue
Gross profit
Operating expense
-25.79%1.38M
-50.60%1.62M
-48.79%9.65M
-59.71%1.8M
-40.00%2.71M
-86.19%1.87M
-75.21%3.28M
-67.32%18.84M
-69.32%4.46M
-60.24%4.52M
Selling and administrative expenses
-16.19%1.28M
-41.77%1.57M
-36.76%8.13M
-45.99%1.77M
-31.35%2.13M
-56.66%1.53M
-31.60%2.7M
-37.64%12.86M
-25.70%3.28M
-32.54%3.1M
-General and administrative expense
-16.19%1.28M
-41.77%1.57M
-36.76%8.13M
-45.99%1.77M
-31.35%2.13M
-56.66%1.53M
-31.60%2.7M
-37.64%12.86M
-25.70%3.28M
-32.54%3.1M
Research and development costs
-69.03%105K
-92.31%44K
-74.66%1.52M
-97.96%24K
-58.98%580K
-96.68%339K
-94.13%572K
-84.11%5.98M
-88.76%1.18M
-79.89%1.41M
Operating profit
25.79%-1.38M
50.60%-1.62M
47.97%-9.65M
59.71%-1.8M
40.00%-2.71M
86.12%-1.87M
74.78%-3.28M
65.87%-18.54M
68.93%-4.46M
59.96%-4.52M
Net non-operating interest income expense
0.00%62K
-13.64%76K
21.77%358K
-23.48%101K
-3.60%107K
37.78%62K
1,366.67%88K
1,937.50%294K
13,300.00%132K
2,320.00%111K
Non-operating interest income
0.00%62K
-13.64%76K
21.77%358K
-23.48%101K
-3.60%107K
37.78%62K
--88K
--294K
--132K
--111K
Other net income (expense)
-3.3M
0
-3.3M
Special income (charges)
----
----
---3.3M
--0
---3.3M
----
----
--0
--0
--0
-Less:Impairment of capital assets
----
----
--3.3M
--0
--3.3M
----
----
--0
--0
--0
Income before tax
26.68%-1.32M
51.62%-1.54M
30.98%-12.59M
60.81%-1.69M
-34.06%-5.91M
86.53%-1.8M
75.44%-3.19M
64.67%-18.25M
59.88%-4.32M
60.97%-4.41M
Income tax
Net income
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
Net income continuous Operations
26.68%-1.32M
51.62%-1.54M
30.98%-12.59M
60.81%-1.69M
-34.06%-5.91M
86.53%-1.8M
75.44%-3.19M
64.67%-18.25M
59.88%-4.32M
60.97%-4.41M
Net income discontinuous operations
--0
--0
128.38%7.33M
--0
321.28%13.47M
---2.38M
---3.77M
---25.83M
---2.89M
---6.09M
Minority interest income
Net income attributable to the parent company
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
Basic earnings per share
71.04%-0.53
80.63%-0.62
88.91%-2.25
78.92%-0.7
164.39%3.11
70.29%-1.83
46.67%-3.2
23.18%-20.28
30.83%-3.32
7.12%-4.83
Diluted earnings per share
71.04%-0.53
80.63%-0.62
88.91%-2.25
78.92%-0.7
156.31%2.72
70.29%-1.83
46.67%-3.2
23.18%-20.28
30.83%-3.32
7.12%-4.83
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000-91.05%297K00
Operating revenue --0--0--0--0--0--0--0-91.05%297K--0--0
Cost of revenue
Gross profit
Operating expense -25.79%1.38M-50.60%1.62M-48.79%9.65M-59.71%1.8M-40.00%2.71M-86.19%1.87M-75.21%3.28M-67.32%18.84M-69.32%4.46M-60.24%4.52M
Selling and administrative expenses -16.19%1.28M-41.77%1.57M-36.76%8.13M-45.99%1.77M-31.35%2.13M-56.66%1.53M-31.60%2.7M-37.64%12.86M-25.70%3.28M-32.54%3.1M
-General and administrative expense -16.19%1.28M-41.77%1.57M-36.76%8.13M-45.99%1.77M-31.35%2.13M-56.66%1.53M-31.60%2.7M-37.64%12.86M-25.70%3.28M-32.54%3.1M
Research and development costs -69.03%105K-92.31%44K-74.66%1.52M-97.96%24K-58.98%580K-96.68%339K-94.13%572K-84.11%5.98M-88.76%1.18M-79.89%1.41M
Operating profit 25.79%-1.38M50.60%-1.62M47.97%-9.65M59.71%-1.8M40.00%-2.71M86.12%-1.87M74.78%-3.28M65.87%-18.54M68.93%-4.46M59.96%-4.52M
Net non-operating interest income expense 0.00%62K-13.64%76K21.77%358K-23.48%101K-3.60%107K37.78%62K1,366.67%88K1,937.50%294K13,300.00%132K2,320.00%111K
Non-operating interest income 0.00%62K-13.64%76K21.77%358K-23.48%101K-3.60%107K37.78%62K--88K--294K--132K--111K
Other net income (expense) -3.3M0-3.3M
Special income (charges) -----------3.3M--0---3.3M----------0--0--0
-Less:Impairment of capital assets ----------3.3M--0--3.3M----------0--0--0
Income before tax 26.68%-1.32M51.62%-1.54M30.98%-12.59M60.81%-1.69M-34.06%-5.91M86.53%-1.8M75.44%-3.19M64.67%-18.25M59.88%-4.32M60.97%-4.41M
Income tax
Net income 68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M
Net income continuous Operations 26.68%-1.32M51.62%-1.54M30.98%-12.59M60.81%-1.69M-34.06%-5.91M86.53%-1.8M75.44%-3.19M64.67%-18.25M59.88%-4.32M60.97%-4.41M
Net income discontinuous operations --0--0128.38%7.33M--0321.28%13.47M---2.38M---3.77M---25.83M---2.89M---6.09M
Minority interest income
Net income attributable to the parent company 68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M
Basic earnings per share 71.04%-0.5380.63%-0.6288.91%-2.2578.92%-0.7164.39%3.1170.29%-1.8346.67%-3.223.18%-20.2830.83%-3.327.12%-4.83
Diluted earnings per share 71.04%-0.5380.63%-0.6288.91%-2.2578.92%-0.7156.31%2.7270.29%-1.8346.67%-3.223.18%-20.2830.83%-3.327.12%-4.83
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data